4hartmann I J, Groeneweg M, Ouerojc, et al. The prognostic signifi- cance of subclinical hepatic encephalopathy [J]. Am J Gastroen- terol,2000,95:2029 - 2034.
5Das A, Dhiman RK, Saraswat VA, et al. Prevalence and natural his- tory of subclinical hepatic encephalopathy in cirrhosis [ J]. J Gas- troenterol Hepatol,2007,16:531 - 535.
6Gupta A, Dhiman RK, Kumari S, et al. Role of small intestinal bac- terial overgrowth and delayed gastrointestinal transit time in cirrhot- ic patients with minimal hepatic encephalopathy [J]. J Hepatol, 2010,53:849 - 855.
7Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy [J]. Nat Rev Gastroenterol Hepatol, 2010,7:515 - 525.
8Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health - related quality of life in patients with cirrho- sis who have minimal hepatic encephalopathy [ J]. Hepatology,2007,45:549 - 559.
9Sharma P, Sharma BC, Puri V, et al. An open - label randomized controlled trial of laetulose and probioties in the treatment of mini- real hepatic eneephalopathy [J]. Eur J Gastroenterol Hepatol, 2008,20:506 - 511.
